![All of the patients had autoantibodies associated with Sjogren's disease, but only a few patients had SSA antibodies, which are the only autoantibodies in the official America-European diagnostic criteria for Sjogren's disease [76]. Nonetheless, these patients all met the necessary clinical criteria and demonstrated autoreactivity through the presence of autoantibodies directed towards salivary and lacrimal gland antigens; the diagnostic criteria may have to be expanded to include additional autoantibodies. Furthermore, the expression of SSA versus SP1/CA6/ PSP may denote different stages of disease and/ or different types of Sjogren's disease that are driven by different metabolic and immunologic abnormalities](https://pbs.twimg.com/media/G0HJUjebYAASCte.jpg?name=small&format=webp)
ALT All of the patients had autoantibodies associated with Sjogren's disease, but only a few patients had SSA antibodies, which are the only autoantibodies in the official America-European diagnostic criteria for Sjogren's disease [76]. Nonetheless, these patients all met the necessary clinical criteria and demonstrated autoreactivity through the presence of autoantibodies directed towards salivary and lacrimal gland antigens; the diagnostic criteria may have to be expanded to include additional autoantibodies. Furthermore, the expression of SSA versus SP1/CA6/ PSP may denote different stages of disease and/ or different types of Sjogren's disease that are driven by different metabolic and immunologic abnormalities

ALT To All Our Patients, We received unfortunate news from the Doctors of BC that MSP is not willing to discuss the upcoming changes to group fee codes starting Sept 1, 2025. The result is that we will need to abandon our group-based clinic model. MSP's unwillingness to discuss the fate of our already underserviced patients results in our moving forward with a plan we were hoping to avoid. Our next step is to let you, our patients, and other partners know so you can mobilize and advocate from a grass roots perspective. We will also be

ALT HAN LONS MISSIO millionsmissingbc Our next step is to let you, our patients, and other partners know so you can mobilize and advocate from a grass roots perspective. We will also be moving forward with a media and social media campaign including a press release. Key message: "Over 5,000 patients with Long COVID, Chronic Fatigue Syndrome, and Fibromyalgia losing access to care in September" I have included a link to our clinic model that outlines the cost effectiveness and overall cost-savings to the system: https://www.dropbox.com/scl/fi/10erugOn256wle wwo25mr/Group-Medical-Visits-Cost-Effectiveness-Paper-May-24-2025.pdf? rlkey=hrw51k7tfxwo8c4n3caydm4y6&dl=0

ALT SAI LONSMISSEO millionsmissingbc ... We will continue to advocate for our underserviced population and would appreciat any help you can provide. Feel free to share this information widely. We will also keep you posted with advice on how to organize and help us prevent this regrettable outcome. We will continue to run groups, business as usual, until the end of August 2025 in the hopes that the situation will be resolved by then. After that, we will be able to see new patients for a consult and do the Group Medical Follow-Up Visits. Everything else will shut down. We will need to return most of your care to your Primacy Care Provider (if you have one). We will no longer

ALT millionsmissingbc until the end of August 2025 in the hopes that the situation will be resolved by then. After that, we will be able to see new patients for a consult and do the Group Medical Follow-Up Visits. Everything else will shut down. We will need to return most of your care to your Primacy Care Provider (if you have one). We will no longer be able to prescribe and provide prescription renewals through Group Medication Visits. Thanks, Ric - CGP Clinical Professor Ric Arseneau, MD FRCPC MA(Ed) MBA FACP




















